Structure-Based Drug Design for Pharma
Apr 17, 2012, 03:20 AM
by
Michael Croft
Wall Street Journal | Computer-aided drug design (or structure-based design) is taking off in pharma with Pfizer, Lilly, GlaxoSmithKline, and Sanofi all using structure-based design in recently launched or late-stage compounds.
April 17, 2012 | Computer-aided drug design (or structure-based design) is taking off in pharma with Pfizer, Lilly, GlaxoSmithKline, and Sanofi all using structure-based design in recently launched or late-stage compounds. Using the key and lock analogy, structure-based design hopes to be more deliberate than traditional drug discovery, and as a result, more cost effective. Wall Street Journal